Literature DB >> 11441554

CT appearance of disseminated peritoneal adenomucinosis.

R E Bechtold1, M Y Chen, B W Loggie, S L Jackson, K Geisinger.   

Abstract

Disseminated peritoneal adenomucinosis (DPAM) is a relatively rare cause of pseudomyxoma peritonei, marked by peritoneal lesions with abundant extracellular mucin and little cytologic atypia among exfoliated tumor cells, and usually associated with appendiceal adenomas. Peritoneal mucinous carcinomatosis (PMCA) also causes diffuse peritoneal tumor but is marked by neoplastic mucinous epithelium with cytologic features of carcinoma and associated with appendiceal, colon, gastric, or small bowel carcinoma. Compared with PMCA, DPAM has a different distribution of disease and a significantly better prognosis. DPAM is characterized by the lack of lymph node involvement, with primarily superficial peritoneal involvement, and a relatively benign, relapsing course over many years. Dominant primary masses may not be evident in DPAM. Despite considerable overlap in the two main causes of pseudomyxoma peritonei, there are features of the two that may help differentiate between them. We present the computed tomographic appearance of DPAM in a series of seven cases and emphasize characteristics of the disease.

Entities:  

Mesh:

Year:  2001        PMID: 11441554     DOI: 10.1007/s002610000185

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  7 in total

Review 1.  Spectrum of mucin-producing neoplastic conditions of the abdomen and pelvis: cross-sectional imaging evaluation.

Authors:  Nam Kyung Lee; Suk Kim; Hyun Sung Kim; Tae Yong Jeon; Gwang Ha Kim; Dong Uk Kim; Do Youn Park; Tae Un Kim; Dae Hwan Kang
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  [Unclear ascites in a young male patient].

Authors:  M Krix; I Dornacher; K H Seitz; H Schlemmer
Journal:  Radiologe       Date:  2004-01       Impact factor: 0.635

3.  Enhanced computed tomography imaging features predict tumor grade in pseudomyxoma peritonei.

Authors:  Pengtao Sun; Xinbao Li; Lingling Wang; Rengui Wang; Xuechao Du
Journal:  Quant Imaging Med Surg       Date:  2022-04

4.  Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells.

Authors:  Jerome T O'Connell; James S Tomlinson; Alice A Roberts; Kathryn F McGonigle; Sanford H Barsky
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

5.  Malignant glomus tumor of the peritoneum: case report.

Authors:  Sandra Baleato-González; Roberto García-Figueiras; Maria Virginia Trujillo-Ariza; Juan Jose Carrera-Álvarez
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

6.  Pseudomyxoma peritonei extending to the lower extremity: a case report.

Authors:  Min Wook Joo; Yang-Guk Chung; Soo Young Hur; Ahwon Lee; Chan Kwon Jung; Won-Hee Jee; Jong Ho Kim
Journal:  World J Surg Oncol       Date:  2015-07-19       Impact factor: 2.754

7.  Correlation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results.

Authors:  B Klumpp; P Aschoff; N Schwenzer; I Koenigsrainer; S Beckert; C D Claussen; S Miller; A Koenigsrainer; C Pfannenberg
Journal:  Cancer Imaging       Date:  2013-12-30       Impact factor: 3.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.